MTTP
Microsomal triglyceride transfer protein large subunit
Also known as: ABL, MTP, MTP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P55157
- Gene
- MTTP
- Ensembl
- ENSG00000138823
- Chromosome
- 4
- Canonical length
- 894 aa
- Protein class
- Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Endoplasmic reticulum,Cytosol
- Secretome location
- Intracellular and membrane
OverviewNCBI Gene
MTP encodes the large subunit of the heterodimeric microsomal triglyceride transfer protein. Protein disulfide isomerase (PDI) completes the heterodimeric microsomal triglyceride transfer protein, which has been shown to play a central role in lipoprotein assembly. Mutations in MTP can cause abetalipoproteinemia. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
894 residues, UniProt reviewed canonical sequence.
>P55157|MTTP
1 MILLAVLFLC FISSYSASVK GHTTGLSLNN DRLYKLTYST EVLLDRGKGK LQDSVGYRIS
61 SNVDVALLWR NPDGDDDQLI QITMKDVNVE NVNQQRGEKS IFKGKSPSKI MGKENLEALQ
121 RPTLLHLIHG KVKEFYSYQN EAVAIENIKR GLASLFQTQL SSGTTNEVDI SGNCKVTYQA
181 HQDKVIKIKA LDSCKIARSG FTTPNQVLGV SSKATSVTTY KIEDSFVIAV LAEETHNFGL
241 NFLQTIKGKI VSKQKLELKT TEAGPRLMSG KQAAAIIKAV DSKYTAIPIV GQVFQSHCKG
301 CPSLSELWRS TRKYLQPDNL SKAEAVRNFL AFIQHLRTAK KEEILQILKM ENKEVLPQLV
361 DAVTSAQTSD SLEAILDFLD FKSDSSIILQ ERFLYACGFA SHPNEELLRA LISKFKGSIG
421 SSDIRETVMI ITGTLVRKLC QNEGCKLKAV VEAKKLILGG LEKAEKKEDT RMYLLALKNA
481 LLPEGIPSLL KYAEAGEGPI SHLATTALQR YDLPFITDEV KKTLNRIYHQ NRKVHEKTVR
541 TAAAAIILNN NPSYMDVKNI LLSIGELPQE MNKYMLAIVQ DILRFEMPAS KIVRRVLKEM
601 VAHNYDRFSR SGSSSAYTGY IERSPRSAST YSLDILYSGS GILRRSNLNI FQYIGKAGLH
661 GSQVVIEAQG LEALIAATPD EGEENLDSYA GMSAILFDVQ LRPVTFFNGY SDLMSKMLSA
721 SGDPISVVKG LILLIDHSQE LQLQSGLKAN IEVQGGLAID ISGAMEFSLW YRESKTRVKN
781 RVTVVITTDI TVDSSFVKAG LETSTETEAG LEFISTVQFS QYPFLVCMQM DKDEAPFRQF
841 EKKYERLSTG RGYVSQKRKE SVLAGCEFPL HQENSEMCKV VFAPQPDSTS SGWFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MTTP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 259 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 259 nTPM
- liver: 249 nTPM
- duodenum: 229 nTPM
- kidney: 12 nTPM
- testis: 9 nTPM
- retina: 5.1 nTPM
Single-cell type
- enterocytes: 775 nCPM
- hepatocytes: 327 nCPM
- müller glia: 130 nCPM
- early spermatids: 56 nCPM
- enteric transient amplifying cells: 45 nCPM
- early primary spermatocytes: 44 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- white matter: 3.4 nTPM
- midbrain: 3 nTPM
- hypothalamus: 2.7 nTPM
- medulla oblongata: 2.4 nTPM
- spinal cord: 2.1 nTPM
- thalamus: 2 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MTTP.
Disease | AllUniProt
Conditions MTTP is implicated in, by any mechanism.
- Abetalipoproteinemia (ABL) MIM:200100
Disease | GeneticClinVar
181 pathogenic / likely-pathogenic of 1,245 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Abetalipoproteinaemia
- MTTP-related disorder
- Metabolic syndrome X
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.59
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.03
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cholesterol homeostasis
- chylomicron assembly
- circadian rhythm
- establishment of localization in cell
- lipid metabolic process
- lipoprotein metabolic process
- lipoprotein transport
- low-density lipoprotein particle remodeling
- phospholipid transport
- protein secretion
- response to calcium ion
- triglyceride metabolic process
- triglyceride transport
- very-low-density lipoprotein particle assembly
- plasma lipoprotein particle assembly
Molecular functions
- apolipoprotein binding
- ceramide 1-phosphate transfer activity
- cholesterol transfer activity
- lipid binding
- lipid transporter activity
- phosphatidylcholine transfer activity
- phosphatidylethanolamine transfer activity
- phospholipid transfer activity
- phospholipid transporter activity
- protein heterodimerization activity
- protein-containing complex binding
- triglyceride transfer activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Vitellogenin, N-terminal
- Lipovitellin-phosvitin complex, superhelical domain
- Vitellinogen, beta-sheet N-terminal
- Lipid transport protein, beta-sheet shell
- Lipoprotein amino terminal region
- Microsomal triglyceride transfer protein large subunit
- MTP large subunit, lipid-binding domain
- MTP large subunit, lipid-binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MTTP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MTTP as an antibody target. Whether an autoantibody or antibody against MTTP could matter depends on whether native MTTP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MTTP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MTTP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...